Effect of high nucleated cell concentration on product viability and hematopoietic recovery in autologous transplantation.

David Ming-Hung LinMatthew HiskeyJane HuangCherie NickersonDesmond SaisitthidejAndrea BradfordJoshua WoodburnAndrea LiusAdam SkrzekutEllen TranRebecca Haley

Published in: Transfusion (2020)

Our retrospective investigation provides further supporting evidence that HPC(A) products with cell concentration greater than 3 × 108 NC/mL did not show detrimental effects on the clinical outcomes in patients undergoing autologous PBSC transplantation.

Keyphrases

cell therapy
patients undergoing

bone marrow
single cell

stem cells
mesenchymal stem cells

platelet rich plasma